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Effects of Timing and Extent of Smoking, Type of
Cigarettes, and Concomitant Risk Factors on the Association
Between Smoking and Subclinical Atherosclerosis
Damiano Baldassarre, PhD; Samuela Castelnuovo, Biol Sci; Beatrice Frigerio, Biol Sci;
Mauro Amato, PhD; Jose´ P. Werba, MD; Arienne De Jong, PhD; Alessio L. Ravani, Biol Sci;
Elena Tremoli, PhD; Cesare R. Sirtori, MD, PhD
Background and Purpose—The purpose of this study was to evaluate the effects of timing and extent of smoking, type
of cigarettes, and concomitant vascular risk factors (VRFs) on the association between smoking and carotid
intima-media thickness (C-IMT) in a lipid clinic population.
Methods—1804 patients (869 men, age 21 to 85 year) participated in the study. Smoking habits were recorded and C-IMTs
were measured by B-mode ultrasound. The associations of C-IMT with smoking status (never, former, and current) and
with the cigarettes’ content of tar, nicotine, and carbon monoxide (alone or combined to define “light” or “regular”
cigarettes) as well as the interactions between smoking status, gender, and VRFs were evaluated before and after
adjustment for confounders.
Results—C-IMT was highest in current smokers, lower in former, and lowest in never smokers. C-IMT of former and
current smokers differed only after data adjustment for variables describing the extent and timing of smoking exposure.
C-IMT was positively related to the number of pack-years (number of cigarettes smoked per day [cigarettes/d]
multiplied by number of years smoked/20) in both former and current smokers. There were no differences in C-IMT
between smokers of cigarettes with high or low nicotine, tar, or carbon monoxide content. Both diabetes and
hypertension interacted positively with smoking in determining C-IMTs.
Conclusions—In the present cross-sectional observational investigation, carried out in a cohort of patients attending a lipid
clinic, consumption of light cigarettes does not reduce the atherogenic effect of smoking on C-IMT. The number of
pack-years, cigarettes/d, and years of smoking are relevant covariates in evaluating the effects of smoking on vascular health.
The presence of diabetes or hypertension strengthens the association between smoking and cardiovascular risk. (Stroke. 2009;
40:1991-1998.)
Key Words: atherosclerosis  carotid intima-media thickness  smoking  type of cigarettes  imaging
The harmful effect of smoking on atherosclerosis andcardiovascular health is well established1,2; nevertheless,
many people continue or even start to smoke.
Carotid intima-media thickness (C-IMT), a marker of
subclinical atherosclerosis, has been used as a surrogate end
point to investigate the effects of cigarette smoking.3–12 Some
studies have failed to report a difference in C-IMT between
former and current smokers,6,12 which suggests that the effect
of smoking on vascular walls is irreversible; yet, categoriza-
tions that do not take into account the extent and timing of
smoking may yield misleading conclusions. For example, an
individual with a 40-year history of cigarette smoking who
stopped smoking 1 year ago is classified as a former smoker,
but his/her C-IMT may well not differ from that of a current
smoker. Conversely, a current smoker is included in this
category even if he/she started smoking only a few months
ago with an effect of smoking still negligible.
Other factors potentially modifying the effect of smoking on
the arterial walls are the cigarette contents of tar, nicotine, and
carbon monoxide (CO) as well as the possible interactions with
other common vascular risk factors (VRFs). To the best of our
knowledge, these issues have not been fully investigated until now.
We aimed to investigate: (1) the effects of chronic use of
“light” or “regular” cigarettes (as defined by the tar/nico-
tine/CO content declared on the pack) on C-IMT; (2) to what
extent variables such as the number of years of smoking and
the number of cigarettes smoked per day (cigarettes/d)
modify the effect of smoking on C-IMT; and (3) whether
there is a synergy between smoking, gender, and conven-
tional VRFs in patients at high risk of cardiovascular disease.
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Materials and Methods
Patients
Consecutive patients (n1804, 869 men, age-range 21 to 85 years),
attending for the first time the University Centre for Dyslipidemias - E.
Grossi Paoletti (Niguarda Hospital, Milan, Italy) had their C-IMT
measured by B-mode ultrasound. Patients attend this Lipid Clinic
either spontaneously or referred by general practitioners.
Data from medical history, physical examination, and laboratory
determinations were collected. Subjects were carefully questioned
face-to-face about smoking habits, including the year when smoking
began (and ended, for former smokers), number of cigarettes/d, and
the unique or predominant cigarette brand used. Data about ciga-
rettes’ content of tar, nicotine, and CO were collected from the
information reported on the pack. For former smokers, years elapsed
since smoking cessation (YESSC) was calculated. The extent of
cigarette exposure, referred as “pack-years,” was calculated as:
number of cigarettes smoked per day multiplied by number of years
smoked/20.
Patients were classified according to their smoking status as never,
former, and current smokers. Never smokers (n1113) were defined
as those who had never smoked any cigarette in their lifetime.
Current smokers (n315) were defined as those who were smokers
at enrollment and had a pack-years 0.6. Former smokers (n376)
were defined as those who had a pack-years 0.6 but had not
smoked for at least 1 year before their interview. Smokers of cigars
and other tobacco products, cigarette consumers with a pack-years
0.6, or those who had stopped smoking throughout the year preceding
the interview were excluded because equivocally classifiable.
Patients were considered hypercholesterolemics or hypertriglyc-
eridemics if plasma concentrations of LDL-cholesterol or triglycer-
ides were 4.14 and 1.71 mmol/L, respectively, or when they were
being treated with lipid-lowering drugs; hypoalphalipoproteinemic if
HDL-C levels were 1.04 mmol/L (in males) or 1.3 mmol/L (in
females); hypertensive if systolic or diastolic blood pressure were
140 and 95 mm Hg, respectively, or when they were on treatment
with antihypertensive drugs; and diabetics if blood glucose concen-
trations were 7.01 mmol/L or they were being treated with insulin
or oral hypoglycemic drugs.
The study complies with the Declaration of Helsinki and was
approved by the Hospital Institutional Review Board. Informed
consent was obtained from all patients.
B-Mode Ultrasound Examinations
C-IMT was measured in real-time using the electronic caliper of the
ultrasonic device. The ultrasonic standardized protocol, the intra- and
interobserver repeatability, and the rationale for using this clinically
applicable approach rather than an automated edge-detection system
were described previously.13 Scanning was performed by trained
sonographers unaware of the data on smoking. The ultrasonic
protocol requires the visualization of the near and far walls of the
right and left carotids in 3 different projections: anterior, lateral, and
posterior (approximately 30 carotid segments per patient). The
ultrasonic variables used in the statistical analyses were the mean
IMT of common carotids (CC-IMTmean), bifurcations (Bif-IMTmean),
internal carotid arteries (ICA-IMTmean), and of the whole carotid tree
(IMTmean). The highest IMT value among the 30 segments was
defined as the Maximal IMT (IMTmax).
Lipids
Fasting total cholesterol, HDL-cholesterol, and triglycerides were
determined in fresh serum by enzymatic methods.14,15 LDL-choles-
terol was calculated by the Friedewald formula.16
Statistical Analysis
Continuous and categorical data are expressed as meanSD and
number (percentage), respectively. Variables were tested for normal
distribution using Kolmogorow-Smirnov test and those with a
skewed distribution (ie, triglycerides and C-IMT) were log trans-
formed. Group comparisons for continuous and categorical variables
were performed by ANOVA and 2 test, respectively. Correlations
were assessed by Pearson analysis. Multiple regression analysis was
used to confirm the independence of the relationships between
variables related to timing/extent of smoking and C-IMT.
Covariance analysis (General Linear Models) was used to adjust
for confounding factors and to evaluate interactions between smok-
ing habits, gender, and VRFs.
To compare C-IMTs of high/low-tar, high/low-CO, and high/low-
nicotine cigarette consumers, 4 models were run using IMTmean or
IMTmax as dependent variables and possible confounders as inde-
pendent variables. The first model was run without any adjustment;
the second by adjusting for age and gender (the variables most
consistently associated with C-IMT13); the third by adding, among
covariates, variables related to the amount of cigarettes smoked
(years of smoking, cigarettes/d); and the fourth by adding all possible
confounders.
Statistical significance was assumed if 2-tailed P was0.05. Data
were analyzed using SPSS version 13.0.
Results
Table 1 shows the characteristics of subjects stratified accord-
ing to smoking habits. Age- and gender-adjusted C-IMTs in
both current and former smokers were significantly larger
than in never-smokers, whereas the difference between
former and current smokers was not significant (Table 1).
When analyses were adjusted for confounding factors (listed
in the figure legend), C-IMTs turned out to be significantly
higher in current than in former smokers (Figure 1).
Effect of Cigarette Smoking According to Extent
and Timing of Exposure
To determine whether the atherogenic effect of smoking is
dose-dependent, C-IMT was plotted against pack-years (Fig-
ure 2). Carotid IMTmean increased with pack-years in both
former and current smokers; no interaction was found be-
tween pack-years and whether the smoking status was
“former” or “current.” Similar findings were obtained when
C-IMTmax (r0.34 and r0.37 for former and current smok-
ers, respectively; both P0.0001) or single-segment ultrasonic
variables (CC-IMTmean, Bif-IMTmean and ICA-IMTmean) were
considered (lowest r0.32; all P0.0001).
Effect of “Light” and “Regular” Cigarettes
(Individual Effects of Tar, Nicotine, and CO)
To evaluate whether the atherogenic effect of smoking
depends on the tar, nicotine, or CO content of the cigarettes
smoked, current smokers were stratified into consumers of
high/low-tar, high/low-nicotine, and high/low-CO cigarettes.
Cigarettes were classified as low-tar when the tar content
reported on the pack was 7 mg, as low-nicotine when the
nicotine content was 0.7 mg, and as low-CO when the CO
content was 7 mg.
Table 2 shows the results of covariance analyses of the use
of high/low-tar, high/low-nicotine, and high/low-CO ciga-
rettes on C-IMT. For each of these stratifications, 4 models
were calculated using IMTmean or IMTmax as dependent
variables and possible confounding factors as independent
variables. No differences in IMTmean were detected between
high/low-tar or high/low-CO consumers. Differences in IMT-
max between users of high/low-tar cigarettes became statisti-
cally significant after adjustment for age and gender, years of
smoking, and cigarettes/d (Table 2, lines 2 and 3), but
1992 Stroke June 2009
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differences were again not significant after adjusting for other
possible confounders (line 4).
Significant differences in IMTmean and IMTmax were ob-
served when high- and low-nicotine cigarettes users were
compared (Table 2, line 5); however, after adjustment for
confounders, the differences in IMTmean lost statistical
significance, whereas those in IMTmax remained close to
statistical significance in each model considered (Table 2,
lines 6 to 8). Similar results were obtained when analyses
were performed for pooled current and former smokers,
and also when YESSC was added to covariates (data not
shown).
The last 3 lines in Table 2 show the analyses of C-IMT
differences between smokers of low-tar or low-nicotine or
low-CO cigarettes and never smokers. In these models,
C-IMTs of never smokers were always significantly smaller
than those of smokers, even of the supposedly less toxic
cigarette brands. Statistical significances were much greater
Table 1. Characteristics of Subjects Stratified Into Never, Former, and Current Smokers
















Gender (female/male), n 755/358 78/298 102/213 0.0001* 0.0001* 0.0001* 0.001*
Age, y 56.614.0 56.711.5 50.711.8 0.0001 n.s. 0.0001 0.0001
BMI, kg/m2 24.33.5 26.03.5 24.93.2 0.0001 0.0001 0.016 0.0001
Systolic blood pressure, mm Hg 13116 13217 12615 0.0001 n.s. 0.0001 0.0001
Diastolic blood pressure, mm Hg 819 819 799 0.112 n.s. n.s. n.s.
Blood serum concentrations
Total cholesterol, mmol/L 6.531.48 6.041.37 6.351.42 0.0001 0.0001 n.s. 0.017
HDL-cholesterol, mmol/L 1.420.36 1.270.34 1.240.39 0.0001 0.0001 0.0001 n.s.
LDL-cholesterol, mmol/L 4.401.40 3.991.30 4.221.35 0.0001 0.0001 n.s. 0.064
Triglycerides, mmol/L 1.311.87 1.761.25 2.092.39 0.0001† n.s.† 0.0001† 0.074†
Blood glucose, mmol/L 5.231.00 5.511.17 5.120.95 0.0001 0.0001 n.s. 0.0001
Pharmacological treatments
Hypoglycemic drugs, n (%) 24 (2.2) 21 (5.6) 14 (4.4) 0.002 0.001 0.026 0.308
Antihypertensive, n (%) 99 (8.9) 47 (12.5) 22 (7) 0.034 0.029 0.169 0.011
Resins, n (%) 71 (7.6) 17 (5.8) 6 (2.2) 0.006 0.178 0.0001 0.026
Fibrates, n (%) 98 (10.5) 52 (17.7) 51 (19) 0.000 0.001 0.0001 0.388
Statins, n (%) 227 (24.4) 83 (28.3) 59 (22) 0.206 0.101 0.237 0.052
Years of statins therapy 3.32.7 3.73.3 3.93.5 0.333† 0.998† 0.524† 0.999†
Smoking variables
Years of smoking // 24.611.5 31.412.3 // // // 0.0001
Cigarettes/d // 22.614.4 16.49.6 // // // 0.0001
Pack-years // 29.527.9 26.621.3 // // // 0.046
Tar, mg/cigarette // 9.92.3 8.03.0 // // // 0.0001
Nicotine, mg/cigarette // 0.860.19 0.680.26 // // // 0.0001
Carbon monoxide, mg/cigarette // 9.52.2 8.22.8 // // // 0.0001
YESSC, y // 1410 // // // // //
Alcohol variables
Wine consumers, n (%) 483 (43.6) 223 (60.1) 148 (47.3) 0.0001 0.0001 0.251 0.001
Beer consumers, n (%) 24 (2.2) 15 (4.0) 21 (6.7) 0.0001 0.051 0.0001 0.115
Spirits consumers, n (%) 15 (1.4) 8 (2.2) 15 (4.8) 0.001 0.284 0.0001 0.057
Ultrasonic variables, mm
CC-IMTmean 0.850.23 0.930.33 0.950.21 0.0001† 0.0001† 0.0001† n.s.†
Bif-IMTmean 1.070.38 1.220.47 1.270.37 0.0001† 0.0001† 0.0001† n.s.†
ICA-IMTmean 0.870.34 0.990.41 0.980.33 0.0001† 0.0001† 0.0001† n.s.†
IMTmean 0.930.27 1.050.34 1.070.25 0.0001† 0.0001† 0.0001† n.s.†
IMTmax 1.640.70 1.870.81 1.900.66 0.0001† 0.0001† 0.0001† n.s.†
Data are meansSD. †P value obtained after log-transformation; *P values obtained by 2. BMI indicates body mass index; HDL, high-density lipoprotein; LDL,
low-density lipoprotein; YESSC, years elapsed since smoking cessation; CC, common carotid; Bif, bifurcation; ICA, internal carotid artery; IMT, intima-media thickness;
P values of ultrasonic variables are adjusted for age and gender.
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than those observed in the high/low-tar, high/low-nicotine,
and high/low-CO comparisons.
Effect of “Light” and “Regular” Cigarettes
(Combined Effects of Tar, Nicotine, and CO)
Cigarettes were defined as “light” or “regular” on the basis of
the simultaneous presence of the 3 components (tar, nicotine,
and CO) below or above the selected respective thresholds (7,
0.7, and 7 mg). No difference in C-IMTs between smokers of
light or regular cigarettes was detected (all P0.05). Similar
results were obtained when the data were analyzed for
moderate (pack-years 30) or heavy (pack-years 30)
smokers separately (all P0.05).
To ensure that between-group differences in the extent of
smoking exposure had not introduced a bias in these results,
a further analysis was performed by comparing C-IMT
between 71 smokers of light cigarettes and 71 smokers of
regular cigarettes matched for age, gender, and pack-years
(Figure 3). Again, no differences between-groups were found
either before or after adjustment of the analysis for all
possible confounders considered (listed in the figure legend).
Being these differences are not significant, a power analysis
was performed to quantify type II error. In this analysis, our
sample size of 71 patients per group allowed a 70% power of
detecting as significant (with an alpha error of 0.05) a
difference in IMTmean of 0.095 mm, assuming a standard
deviation of 0.27 mm.
All detected differences between light and regular ciga-
rettes consumers, even those closest to the statistical signifi-
cance, were negligible compared with those between smokers
(either current or former) and never-smokers.
Multiple Regression Analyses
In 5 multivariate models performed by entering each one of
the 5 ultrasonic variables considered as dependent variable,
and the variables listed in Table 1 as independent (excluding
pack-years because of colinearity with cigarettes/d and years
of smoking), cigarettes/d was the only variable retaining
statistical significance (P0.0001 in all the models) after the
stepwise selection of the multivariate model, whereas all the
others, including tar, nicotine, and CO, did not.
Interaction Between Smoking Habits, Gender, and
Vascular Risk Factors
To investigate whether smoking habits affect C-IMT by
interacting with gender or other VRFs, we stratified never and
current smokers according to gender or the presence of
hypertension, diabetes, hypertriglyceridemia, and hypoal-
Figure 1. Intima-media thickness (IMT;
meansSEM) in former and current
smokers after analyses were adjusted for
age, gender, BMI, log-triglycerides, HDL-
cholesterol, LDL-cholesterol, blood glu-
cose, uric acid, blood pressure, pack-
years, tar, nicotine, CO, alcohol
consumption (wine, beer, and spirit con-
sumption), and pharmacological treat-
ments (statins, resins, fibrates, hypogly-
cemic and antihypertensive drugs). CC
indicates common carotid; Bif, bifurca-
tion; ICA, internal carotid artery.
Figure 2. Correlation between log
C-IMTmean and log pack-years in current
and former smokers. Interaction was cal-
culated by ANCOVA analyses adjusted
for gender, age, BMI, SBP, LDL-choles-
terol, tar, nicotine, CO, and (for former
smokers) YESSC.
1994 Stroke June 2009
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phalipoproteinemia (frequencies in supplemental Table I,
available online at http://stroke.ahajournals.org). The interac-
tion with hypercholesterolemia was not investigated be-
cause most patients were hypercholesterolemic. Covari-
ance analyses using C-IMT as the dependent variable and
hypertension and smoking as independent variables
showed that smoking habit and hypertension were both
independent determinants of C-IMT, with a significant
interaction between hypertension and smoking habit (Figure
4, top panel). Similar results were obtained when subjects
were stratified according to presence or absence of diabetes
(Figure 4, bottom panel). No interaction with smoking habit
was observed when patients were stratified according to
gender, hypertriglyceridemia, or hypoalphalipoproteinemia
(all P0.05).
Discussion
The major finding of the present study is that no relevant
difference in C-IMT is detectable between consumers of
“light” and “regular” cigarettes. In some analyses, C-IMT
seems to be slightly higher in regular cigarette consumers,
but differences were not significant and negligible com-
Table 2. Tar, Nicotine and Carbon Monoxide (CO) as Determinants of Carotid IMTmean and IMTmax in Current Smokers (n315)
IMTmean IMTmax
Adjustment B SE P (95% CI) B SE P (95% CI)
TAR 7 (n65) vs TAR 7 (n250)
None 0.013 0.046 0.773 (0.103; 0.076) 0.129 0.114 0.257 (0.352; 0.095)
Age, gender 0.046 0.036 0.206 (0.117; 0.025) 0.214 0.094 0.023 (0.398;0.029)
Age, gender, years of smoking, cigarettes/d 0.039 0.035 0.272 (0.108; 0.031) 0.202 0.093 0.031 (0.386;0.018)
Full model 0.016 0.068 0.820 (0.149; 0.118) 0.220 0.184 0.231 (0.581; 0.141)
Nicotine 0.7 mg (n130) vs Nicotine 0.7 mg (n185)
None 0.098 0.037 0.008 (0.171;0.026) 0.274 0.092 0.003 (0.455;0.092)
Age, gender 0.044 0.029 0.136 (0.101; 0.014) 0.148 0.076 0.052 (0.298; 0.001)
Age, gender, years of smoking, cigarettes/d 0.039 0.029 0.174 (0.095; 0.017) 0.140 0.076 0.065 (0.289; 0.009)
Full model 0.013 0.045 0.781 (0.102; 0.077) 0.038 0.123 0.756 (0.204; 0.28)
CO 7 mg (n63) vs CO 7 mg (n252)
None 0.002 0.046 0.963 (0.088; 0.093) 0.084 0.115 0.466 (0.310; 0.142)
Age, gender 0.005 0.047 0.923 (0.088; 0.097) 0.084 0.117 0.471 (0.315; 0.146)
Age, gender, years of smoking, cigarettes/d 0.004 0.037 0.911 (0.07; 0.078) 0.085 0.099 0.388 (0.280; 0.109)
Full model 0.101 0.064 0.115 (0.025; 0.227) 0.160 0.174 0.358 (0.182; 0.503)
Never smokers (n1113) vs TAR 7 mg 0.133 0.033 0.0001 (0.198;0.069) 0.174 0.089 0.051 (0.349;0.000)
Never smokers (n1113) vs Nicotine 0.7 mg 0.117 0.024 0.0001 (0.165;0.069) 0.197 0.067 0.003 (0.327;0.066)
Never smokers (n1113) vs CO 7 mg 0.147 0.033 0.0001 (0.212;0.082) 0.223 0.090 0.014 (0.400;0.046)
The last 3 rows of the table refer to low-tar, low-nicotine, and low-CO cigarette consumers vs never smokers.
B indicates non-standardized coefficient; SE, standard error of B.
Full models are adjusted for: age, gender, tar, or nicotine or CO, BMI, log-triglycerides, HDL-cholesterol, LDL-cholesterol, blood glucose, uric acid, systolic blood
pressure, alcohol consumption (wine, beer and spirit consumption), years of smoking, cigarettes/d, and pharmacological treatments (statins, resins, fibrates,
hypoglycemic and antihypertensive drugs). The last 3 analyses were adjusted for the same covariates with the exclusion of those related to timing and extent of
smoking (tar or nicotine or CO, years of smoking, cigarettes/d).
Figure 3. C-IMTs (meanSEM) in 71
smokers of “light” cigarettes and 71
smokers of “regular” cigarettes matched
for age, gender, and pack-years. Light
and regular cigarettes were defined by
the simultaneous presence of tar, nico-
tine, and CO below or above the selected
thresholds (7 mg for tar, 0.7 mg for nico-
tine, and 7 mg for CO), respectively. Anal-
yses were adjusted for BMI, log-triglycer-
ides, HDL-cholesterol, LDL-cholesterol,
blood glucose, uric acid, blood pressure,
alcohol consumption (wine, beer, and
spirit), YESSC, cigarettes/d, years of
smoking, and pharmacological treatments
(statins, resins, fibrates, hypoglycemic
and antihypertensive drugs).
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pared with those observed between smokers and never
smokers.
A posteriori estimates of statistical power are meaningful
only when based on a specific alternative hypothesis, such as
an effect size thought to be biologically significant. We have
assumed as biologically significant a C-IMT difference be-
tween light and regular cigarettes consumers equal to at least
50% of the difference observed between regular cigarette
consumers and never smokers. The sample size of 71 patients
per group allowed a 70% power to detect as significant a
difference in IMTmean of 0.095 mm, a value equivalent to the
53% of the difference observed between regular cigarettes
consumers and never smokers. Consequently, our results do
not support the hypothesis that light cigarettes have a less
unfavorable effect than regular cigarettes. As far as we know,
the present study is the first to provide detailed findings on
this issue. Although previous reports showed that switching
from regular to light cigarettes does not reduce tobacco-
related cardiovascular morbidity,17,18 mistaken beliefs about
the possible benefits of light cigarettes are still widespread
even in countries where considerable efforts have been made
to educate people about the misconception of “light.”19 For
example, one study showed that many smokers use light
cigarettes in the belief that this may reduce the risks of
smoking or as a first step toward stopping smoking; in the
same study, however, most participants declared that they
would much more probably have stopped smoking if they had
known that light cigarettes confer the same risk as regular
ones.20 Information herein reported comparing the athero-
genic effect of light and regular cigarettes is thus not only of
scientific interest but provides strong support for health-
promoting programs.
Another important finding of the present study is that the
inclusion in the analyses of covariates related to lifelong
smoking exposure (pack-years, cigarettes/d, years of smok-
ing, and YESSC) unmask differences between former and
current smokers, thus explaining, at least in part, the lack of
differences in C-IMT between current and former smokers
reported by others.6,12
The present report also indicates that diabetes or hyperten-
sion, but not hypertriglyceridemia or hypoalphalipoproteine-
mia, interact with smoking in determining C-IMT. The
interaction of smoking with diabetes is apparently in contrast
to the study of Kong et al,21 who showed no differences in
C-IMTs between smoking and nonsmoking type 2 diabetics.
It must be emphasized, however, that in Kong’s study former
smokers were classified as nonsmokers, irrespective of
YESSC or smoking duration, and this may have considerably
influenced results.21 Our findings, by contrast, are in line with
those reported in the ARIC study,22 which showed that the
effect of cigarette smoking on C-IMT progression rate in
diabetic patients was almost twice that observed in nondia-
Figure 4. C-IMTs (meanSEM) in never
and current smokers after patients’ strati-
fication according to hypertension or dia-
betes. Analyses were adjusted for age,
gender, BMI, blood pressure, LDL-choles-
terol, HDL-cholesterol, log-triglycerides
and blood glucose, alcohol consumption
(wine, beer, and spirit consumption), and
pharmacological treatments (statins, res-
ins, fibrates, hypoglycemic and antihyper-
tensive drugs). NIDDM indicates noninsu-
lin dependent diabetes mellitus.
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betic patients. Regarding the interaction between cigarette
smoking and hypertension, the present data agree with those
of Liang and coworkers.7
Thus, the identification of atherogenic interactions war-
rants intensified efforts to promote smoking cessation in
patients with diabetes or hypertension.
Finally, we observed that age- and sex-adjusted C-IMTs
increase with the number of pack-years, in both former and
current smokers, thus confirming a direct dose-dependent
relationship between smoking and C-IMT.7,10,23–26 It has also
been suggested that the relation between smoking and C-IMT
may be different for each carotid segment,8 but in our study
pack-years correlated well with C-IMT in each carotid
segment considered.
With regard to possible gender-specific effects, 2 studies
suggested that pack-years are predictive for C-IMT only in
men,27–29 but in these studies men had a higher lifetime
exposure to smoking than women and data were not adjusted
for other smoking variables. In the present study, after data
stratification for pack-years, the atherogenic effect of smok-
ing was equally strong in both sexes (Ptrend 0.0001 for both
men and women after adjustment for all variables included in
Table 1) without any interaction between tertiles of pack-
years and gender (P0.12).
Study Limitations
The present study included patients attending a Lipid Clinic
mostly exposed to dyslipidemia and a variety of other risk
factors and risk-reducing interventions. Hence, despite the
low prevalence of patients treated with lipid lowering drugs
(an issue probably related to the fact that they attended the
clinic for the first time), no conclusions can be drawn from
this study about the effect of light or regular cigarettes
smoking on C-IMT among normolipidemics or subjects from
the general population. Other potential limitations are the
cross-sectional nature of the study (which implies that the
results are based on indirect evidences; ie, self-reported data)
and the inclusion of drug therapies in the statistical analyses
as binary variables (yes/no at the time of assessment) without
taking into account the duration, doses, and efficacy of
therapies. In addition, because the study is focused on carotid
arteries, it does not provide any information about the effect
of light or regular cigarettes consumption on the extent of
atherosclerosis in other vascular districts. Finally, lack of data
about individual socioeconomic status, which was reported to
be associated with both smoking habits30 and C-IMT,31 does
not allow to exclude a potential confounder effect of this
variable on the results reported.
Summary
Having established that smoking is dose-dependently associ-
ated with subclinical carotid atherosclerosis, this study also
shows that the consumption of light cigarettes does not
reduce the atherogenic effect of smoking on C-IMT. Pack-
years, cigarettes/d, years of smoking, and YESSC are impor-
tant covariates that should be taken into account to properly
evaluate in clinical studies the effects of smoking on health.
Finally, both diabetes and hypertension strengthen the asso-
ciation between smoking and atherosclerosis, so that partic-
ular efforts to stop smoking should be made for patients with
these conditions.
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